2 years ago
SAGE
AnalystsRitu BaralRitu Baral's Stock Forecasts
AnalystsRitu Baral
Analyst Ranking
Bottom 3%
#4755 out of 4870 analysts
Average Return
-19.43%
Win Rate
24%7 out of 29
Risk vs Reward
Poor
Good
Ritu Baral's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | +63.21% | $14.76 | $24.09 | 2025-02-05 - 2025-05-01 | Strong Buy |
Acadia Pharmaceuticals IncACAD | +61.25% | $16.62 | $26.80 | 2022-08-08 - 2023-08-07 | Buy |
Insmed IncINSM | +35.86% | $18.46 | $25.08 | 2022-10-21 - 2023-10-20 | Buy |
Insmed IncINSM | +35.65% | $53.55 | $72.64 | 2024-05-29 - 2025-05-01 | Strong Buy |
Albireo Pharma IncALBO | +29.26% | $23.00 | $29.73 | 2017-08-16 - 2018-08-16 | Buy |
Ritu Baral Analyst Color
Get additional color on Ritu Baral's coverage of popular stocks
Ritu Baral's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $44.00 | +82.65% | Initiates Coverage On | 3 months ago |
Sage Therapeutics IncSAGE | 6 | Hold | $9.00 | +20.32% | Maintains | 5 months ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $78.00 | +138.61% | Maintains | 6 months ago |
Alnylam Pharmaceuticals IncALNY | 3 | Strong Buy | $371.00 | +45.42% | Maintains | 6 months ago |
Insmed IncINSM | 3 | Strong Buy | $98.00 | +34.91% | Maintains | 9 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Buy | $390.00 | N/A | Maintains | a year ago |
Ngm Biopharmaceuticals IncNGM | 2 | Hold | $1.55 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Buy | $175.00 | N/A | Maintains | 2 years ago |
Albireo Pharma IncALBO | 2 | Hold | $48.00 | N/A | Downgrades | 2 years ago |
Aptinyx IncAPTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $68.50 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 1 | Buy | $21.00 | N/A | Maintains | 3 years ago |
Spero Therapeutics IncSPRO | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
An2 Therapeutics IncANTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Spruce Biosciences IncSPRB | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Rallybio CorpRLYB | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Gh Research PLCGHRS | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Atai Life Sciences NvATAI | 2 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Vera Therapeutics IncVERA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Terns Pharmaceuticals IncTERN | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $47.00 | N/A | Downgrades | 5 years ago |
Pliant Therapeutics IncPLRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Orchard Therapeutics PLCORTX | 1 | Buy | $270.00 | N/A | Initiates Coverage On | 6 years ago |
Axon Enterprise IncAXON | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Allena Pharmaceuticals IncALNAQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Trean Insurance Group IncTIG | 1 | Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.